Myofascial Pain Syndromes News - LARVOL Sigma

Myofascial Pain Syndromes

Welcome, Profile Billing Logout

35 Mechanisms of Action

«1 2 3 456 7 8 »

|||||||||| Enrollment closed: Online Acceptance-based Behavioural Treatment for Fibromyalgia (clinicaltrials.gov) - Apr 16, 2014
P3, N=100, Active, not recruiting, Sponsor: University of Manitoba
Recruiting --> Active, not recruiting

||||||||||  pregabalin / Generic mfg.
Trial withdrawal:  Fibromyalgia of Less Than One Year Duration. Study of Pregabalin (clinicaltrials.gov) -  Apr 10, 2014
P4, N=0, Withdrawn,  Sponsor: Newton-Wellesley Hospital
Recruiting --> Active, not recruiting Not yet recruiting --> Withdrawn

||||||||||  pregabalin / Generic mfg.
Enrollment change:  Fibromyalgia of Less Than One Year Duration. Study of Pregabalin (clinicaltrials.gov) -  Apr 10, 2014
P4, N=0, Withdrawn,  Sponsor: Newton-Wellesley Hospital
Not yet recruiting --> Withdrawn N=76 --> 0

|||||||||| Clinical: TheraFast: Effects of Fasting on Self Efficacy (clinicaltrials.gov) - Apr 10, 2014
P=N/A, N=120, Recruiting, Sponsor: Universität Duisburg-Essen

||||||||||  Savella (milnacipran) / AbbVie, Pierre Fabre
Trial completion:  Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients (clinicaltrials.gov) -  Apr 9, 2014
P=N/A, N=51, Completed,  Sponsor: University of Florida
N=76 --> 0 Recruiting --> Completed

||||||||||  Lodonal (naltrexone low dose oral) / Immune Therap, Statera BioPharma
Enrollment open:  LDN-IM: Low Dose Naltrexone (LDN) Immune Monitoring (clinicaltrials.gov) -  Apr 6, 2014
P=N/A, N=20, Recruiting,  Sponsor: Stanford University
Recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Enrollment change: PROCAIM: Web-Based Survey of Pain, Stress and Complementary and Alternative Medicine (clinicaltrials.gov) - Mar 25, 2014
P=N/A, N=2300, Completed, Sponsor: University of California, Los Angeles
Not yet recruiting --> Recruiting N=1000 --> 2300

|||||||||| Trial termination: Lidocaine Injection and Ischemic Compression on Chronic Pelvic Pain Treatment (clinicaltrials.gov) - Mar 23, 2014
P4, N=30, Terminated, Sponsor: University of Sao Paulo
N=1000 --> 2300 Recruiting --> Terminated; Lidocaine injection group showed significant improvement in pain

|||||||||| Enrollment open: CAMMPS: Comprehensive vs. Assisted Management of Mood and Pain Symptoms (clinicaltrials.gov) - Mar 10, 2014
P3, N=300, Enrolling by invitation, Sponsor: Department of Veterans Affairs
Recruiting --> Terminated; Lidocaine injection group showed significant improvement in pain Not yet recruiting --> Enrolling by invitation

|||||||||| Enrollment open: Dry Needling on Myofascial Trigger Points in Older Adults With Nonspecific Shoulder Pain (clinicaltrials.gov) - Mar 5, 2014
P=N/A, N=60, Recruiting, Sponsor: University of Alcala
Not yet recruiting --> Enrolling by invitation Not yet recruiting --> Recruiting

||||||||||  Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
New P4 trial:  Fibroebre: Discomfort and Psychosocial Difficulties in Fibromyalgia (clinicaltrials.gov) -  Mar 3, 2014
P4, N=66, Completed,  Sponsor: University Rovira i Virgili

|||||||||| Trial completion: Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome (clinicaltrials.gov) - Feb 23, 2014
P=N/A, N=160, Completed, Sponsor: Georgetown University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed

|||||||||| Trial completion: Study of Gulf War Illness (GWI) by Comparing GWI and Healthy Veterans (clinicaltrials.gov) - Feb 23, 2014
P=N/A, N=516, Completed, Sponsor: Georgetown University
Active, not recruiting --> Completed Recruiting --> Completed

||||||||||  duloxetine / Generic mfg.
Trial completion:  A Study of Duloxetine in the Treatment of Fibromyalgia (clinicaltrials.gov) -  Feb 22, 2014
P3, N=320, Completed,  Sponsor: Eli Lilly and Company
Recruiting --> Completed No longer recruiting --> Completed

||||||||||  Oratrope (ibutamoren) / Merck (MSD), Lumos Pharma
Trial completion:  Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia (clinicaltrials.gov) -  Feb 22, 2014
P2, N=64, Completed,  Sponsor: Bennett, Robert, M.D.
No longer recruiting --> Completed No longer recruiting --> Completed

||||||||||  Savella (milnacipran) / AbbVie, Pierre Fabre
Trial completion:  Study of Milnacipran for the Treatment of Fibromyalgia (clinicaltrials.gov) -  Feb 22, 2014
P3, N=1200, Completed,  Sponsor: Forest Laboratories
No longer recruiting --> Completed No longer recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Nondrug Treatment Programs for Adults With Fibromyalgia (clinicaltrials.gov) -  Feb 22, 2014
P2, N=300, Completed,  Sponsor: University of Utah
No longer recruiting --> Completed Recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Pain Management Techniques for Fibromyalgia (clinicaltrials.gov) -  Feb 22, 2014
P1/2, N=97, Completed,  Sponsor: University of Michigan
Recruiting --> Completed Recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Shamanic Healing for Women With Temporomandibular Joint Disorders (TMDs) (clinicaltrials.gov) -  Feb 22, 2014
P1, N=25, Completed,  Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting --> Completed No longer recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia (clinicaltrials.gov) -  Feb 22, 2014
P1/2, N=40, Completed,  Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
No longer recruiting --> Completed No longer recruiting --> Completed

|||||||||| Trial completion: Gabapentin in Fibromyalgia Trial (GIFT) (clinicaltrials.gov) - Feb 22, 2014
P2/3, N=150, Completed, Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
No longer recruiting --> Completed No longer recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Efficacy of Acupuncture in the Treatment of Fibromyalgia (clinicaltrials.gov) -  Feb 19, 2014
P1, N=0, Completed,  Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
No longer recruiting --> Completed No longer recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Acupuncture in Fibromyalgia (clinicaltrials.gov) -  Feb 19, 2014
P3, N=0, Completed,  Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
No longer recruiting --> Completed No longer recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Diagnosis and Evaluation of Patients Needing Third Molar (Wisdom Tooth) Extraction and Patients With Chronic Facial Pain (clinicaltrials.gov) -  Feb 19, 2014
P=N/A, N=4000, Completed,  Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
No longer recruiting --> Completed Recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Combining N-of-1 Trials to Assess Fibromyalgia Treatments (clinicaltrials.gov) -  Feb 19, 2014
P4, N=58, Completed,  Sponsor: Tufts Medical Center
Recruiting --> Completed No longer recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Tailored Treatments of Fibromyalgia (clinicaltrials.gov) -  Feb 19, 2014
P2/3, N=312, Completed,  Sponsor: University of Washington
No longer recruiting --> Completed No longer recruiting --> Completed

||||||||||  duloxetine / Generic mfg.
Trial completion:  An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057) (clinicaltrials.gov) -  Feb 19, 2014
P3, N=150, Completed,  Sponsor: Eli Lilly and Company
No longer recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Savella (milnacipran) / AbbVie, Pierre Fabre
Trial completion:  The Effect of Milnacipran in Patients With Fibromyalgia (clinicaltrials.gov) -  Feb 18, 2014
P2, N=37, Completed,  Sponsor: Beth Israel Medical Center
Active, not recruiting --> Completed Recruiting --> Completed

|||||||||| New P4 trial: Strengthening Exercises for Fibromyalgia (clinicaltrials.gov) - Feb 12, 2014
P4, N=60, Completed, Sponsor: Federal University of S

|||||||||| Enrollment change: Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus (clinicaltrials.gov) - Feb 10, 2014
P=N/A, N=75, Completed, Sponsor: University of Michigan
Recruiting --> Completed N=100 --> 75

|||||||||| Trial completion: Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus (clinicaltrials.gov) - Feb 10, 2014
P=N/A, N=75, Completed, Sponsor: University of Michigan
N=100 --> 75 Active, not recruiting --> Completed

||||||||||  Tonmya (cyclobenzaprine SL) / Tonix
Enrollment change:  BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) (clinicaltrials.gov) -  Jan 15, 2014
P2/3, N=200, Recruiting,  Sponsor: Tonix Pharmaceuticals, Inc.
Active, not recruiting --> Completed N=120 --> 200

||||||||||  duloxetine / Generic mfg.
Trial completion:  A Study of Duloxetine in Fibromyalgia (clinicaltrials.gov) -  Jan 15, 2014
P3, N=354, Completed,  Sponsor: Eli Lilly and Company
N=120 --> 200 Active, not recruiting --> Completed

|||||||||| Enrollment open: Pain Sensitivity of Subjects With Fibromyalgia Before and After Repetitive Transcranial Magnetic Stimulation Treatment (clinicaltrials.gov) - Jan 5, 2014
P=N/A, N=72, Recruiting, Sponsor: Centre Hospitalier Esquirol
Active, not recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Trial completion: Clinical Trial Examining Effects of Monosodium Glutamate (MSG) on Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM) (clinicaltrials.gov) - Dec 20, 2013
P=N/A, N=60, Completed, Sponsor: Oregon Health and Science University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed

||||||||||  Tonmya (cyclobenzaprine SL) / Tonix
New P3 trial:  12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients (clinicaltrials.gov) -  Dec 17, 2013
P3, N=120, Enrolling by invitation,  Sponsor: Tonix Pharmaceuticals, Inc.

|||||||||| Trial completion, HEOR: Aquavip: Improving Quality of Life of Fibromyalgia Patients (clinicaltrials.gov) - Dec 17, 2013
P=N/A, N=115, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Tonmya (cyclobenzaprine SL) / Tonix
Enrollment open:  12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients (clinicaltrials.gov) -  Dec 11, 2013
P3, N=120, Enrolling by invitation,  Sponsor: Tonix Pharmaceuticals, Inc.
Active, not recruiting --> Completed Not yet recruiting --> Enrolling by invitation

|||||||||| Trial completion: Multidisciplinary Therapy in the Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=70, Completed, Sponsor: Universidad de Almeria
Not yet recruiting --> Enrolling by invitation Active, not recruiting --> Completed

|||||||||| Trial completion: Physiotherapy and Deontology in the Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome. (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=70, Completed, Sponsor: Universidad de Almeria
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| New P4 trial: Heart Rate Variability in Fibromyalgia - Effects of Strengthening Exercises (clinicaltrials.gov) - Dec 5, 2013
P4, N=66, Completed, Sponsor: Federal University of Espirito Santo

|||||||||| Trial completion: Heart Rate Variability in Fibromyalgia - Effects of Strengthening Exercises (clinicaltrials.gov) - Dec 5, 2013
P4, N=66, Completed, Sponsor: Federal University of Espirito Santo
Active, not recruiting --> Completed Not yet recruiting --> Completed

|||||||||| Enrollment change: Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders (clinicaltrials.gov) - Dec 3, 2013
P2/3, N=58, Completed, Sponsor: Philipps University Marburg Medical Center
Not yet recruiting --> Completed N=100 --> 58

|||||||||| Trial completion: Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders (clinicaltrials.gov) - Dec 3, 2013
P2/3, N=58, Completed, Sponsor: Philipps University Marburg Medical Center
N=100 --> 58 Recruiting --> Completed

|||||||||| Trial completion: SPIN: Sleep and Pain Interventions in Fibromyalgia (clinicaltrials.gov) - Nov 26, 2013
P=N/A, N=113, Completed, Sponsor: University of Florida
Recruiting --> Completed Not yet recruiting --> Completed

|||||||||| Trial initiation date: Neurodynamic Intervention in Fibromyalgia (clinicaltrials.gov) - Nov 19, 2013
P=N/A, N=70, Not yet recruiting, Sponsor: Universidad de Granada
Not yet recruiting --> Completed Initiation date: Apr 2013 --> Jan 2014

|||||||||| Enrollment change: Risk of Falls in Patients With Fibromyalgia (clinicaltrials.gov) - Nov 12, 2013
P=N/A, N=60, Completed, Sponsor: Universidad de Granada
Initiation date: Apr 2013 --> Jan 2014 N=35 --> 60

|||||||||| Trial completion: Risk of Falls in Patients With Fibromyalgia (clinicaltrials.gov) - Nov 12, 2013
P=N/A, N=60, Completed, Sponsor: Universidad de Granada
N=35 --> 60 Recruiting --> Completed

||||||||||  ampreloxetine (TD-9855) / Theravance Biopharma
Trial completion:  Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction. (clinicaltrials.gov) -  Nov 10, 2013
P4, N=61, Completed,  Sponsor: Oslo University Hospital
Recruiting --> Completed Not yet recruiting --> Completed

|||||||||| Trial completion: Coping Skills Training for Adolescents With Fibromyalgia (clinicaltrials.gov) - Oct 31, 2013
P3, N=114, Completed, Sponsor: Children's Hospital Medical Center, Cincinnati
Not yet recruiting --> Completed Recruiting --> Completed